The Recall Desk
SevereFDA (Devices)·Z-2922-2026·Announced 2026-08-19

Surgipro II Sutures Recalled for Potential Sterile Barrier Defects

FDA is recalling Surgipro II sutures due to potential sterile packaging defects that could cause biocontamination and infection.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The source text explicitly states that the defect may lead to infection and loss of vision, which constitutes significant injury reports under the rubric for a score of 4.

Plain-English summary

The U.S. Food and Drug Administration (FDA) is recalling Surgipro II sutures (Model S8698GX) manufactured by Covidien, LP. The recall involves 135,875 units distributed in the United States and numerous international countries. The specific lot number is D5M3438FY, and the UDI-DI is 20612479214716.

The recall is being issued because the product may contain a perforation or tear in the sterile barrier packaging. This defect may result in the biocontamination of the sterile sutures. If used, this contamination may lead to infection, loss of vision if used in ophthalmic procedures, or prolonged surgery.

Healthcare providers and facilities should check their inventory for the affected lot number and stop using these sutures. Consumers should not use these products if they have them in their possession.

The recalled product

Product
Surgipro II S8698GX SURGIPRO II BL 5/0 18 P-13 S8698GX
Manufacturer
Covidien, LP
Affected units
135,875

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • S8698GX UDI-DI 20612479214716 Lot D5M3438FY

Distribution

Distributed nationwide across the United States.